Clinical utility of the AJCC 8th edition pT1 subclassification and impact on practice patterns in stage I seminoma

Rohit R. Badia, Solomon Woldu, Hiten D. Patel, Nirmish Singla, Arnav Srivastava, Joseph G. Cheaib, Phillip M. Pierorazio, Aditya Bagrodia

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: The American Joint Committee on Cancer 8th edition staging guidelines for testicular cancer established a 3 cm cutoff to subclassify stage T1 seminomas (<3 cm = pT1a and ≥3 cm = pT1b). The efficacy of this cutoff in predicting metastatic disease and impact on treatment patterns have not been studied. Methods: We retrospectively reviewed patients with pT1 testicular seminoma in the National Cancer Database from 2004 to 2016. Receiver operating curves were used to determine the efficacy of the 3 cm tumor cutoff in identifying metastatic disease, and multivariable regression was used to compute the effect of tumor size on the rate of adjuvant therapy among Stage I patients. Results: A total of 10,134 patients with pT1 seminoma were evaluated. The current size cutoff of 3 cm for subclassification did not exhibit high discrimination in identifying metastatic disease (area under receiver operating curve: 0.546). Surveillance has grown as the preferred treatment after orchiectomy −32.1% in 2004 to 81.2% in 2015. However, the rate of adjuvant therapy for pT1, Stage I seminomas associated positively with tumor size even with adjustment for year of diagnosis. For tumors above 3 cm, the odds ratio stabilized around 1.9. By using the 3 cm cutoff to guide adjuvant therapy, up to 85% of T1b patients may be overtreated. Conclusion: The 3 cm cutoff for subclassification of Stage I seminoma does not predict metastatic recurrence but is associated with increased receipt of adjuvant therapy. A 3 cm cutoff and the pT1a/b classification may therefore contribute to overtreatment in many young patients with a long life expectancy for whom minimizing adverse effects should be prioritized.

Original languageEnglish (US)
Pages (from-to)136.e19-136.e25
JournalUrologic Oncology: Seminars and Original Investigations
Volume39
Issue number2
DOIs
StatePublished - Feb 2021

Keywords

  • Epidemiology
  • GCT
  • Outcomes
  • Testicular cancer
  • Testis cancer

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint

Dive into the research topics of 'Clinical utility of the AJCC 8<sup>th</sup> edition pT1 subclassification and impact on practice patterns in stage I seminoma'. Together they form a unique fingerprint.

Cite this